{"id":10372,"date":"2026-06-30T10:33:30","date_gmt":"2026-06-30T02:33:30","guid":{"rendered":"https:\/\/regask.com\/?p=10372"},"modified":"2026-06-30T10:33:30","modified_gmt":"2026-06-30T02:33:30","slug":"application-des-bpf-juin-2026","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/gmp-enforcement-june-2026\/","title":{"rendered":"Renforcement du contr\u00f4le des BPF\u00a0: lettres d\u2019avertissement de la FDA, interdiction des importations\u2026"},"content":{"rendered":"<p id=\"ember1956\" class=\"ember-view reader-text-block__paragraph\"><span class=\"TextRun SCXW61959956 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW61959956 BCX0\"><strong>L\u2019application des BPF s\u2019est sensiblement intensifi\u00e9e au milieu de l\u2019ann\u00e9e 2026, et les inspections de fabrication ont repr\u00e9sent\u00e9 la part la plus \u00e9lev\u00e9e d\u2019alertes r\u00e9glementaires \u00e0 risque parmi nos principales tendances en sciences de la vie.<\/strong> Le facteur d\u00e9terminant \u00e9tait une nette augmentation des mesures prises par la FDA am\u00e9ricaine.\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">(<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">une s\u00e9rie de lettres d&#039;avertissement relatives aux BPFc, accompagn\u00e9e d&#039;une augmentation des retenues \u00e0 l&#039;importation<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">)<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0Parall\u00e8lement aux activit\u00e9s d&#039;inspection au Japon et en Am\u00e9rique latine, il s&#039;agit de la tendance ayant la cons\u00e9quence op\u00e9rationnelle la plus directe pour les \u00e9quipes de production et de qualit\u00e9 : le contr\u00f4le et l&#039;application des r\u00e9glementations.\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">n&#039;a pas<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0g\u00e9n\u00e9rer simplement\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">paperasse;<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0il s&#039;arr\u00eate\u00a0<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">produit<\/span><span class=\"NormalTextRun SCXW61959956 BCX0\">\u00a0exp\u00e9dition.<\/span><\/span><span class=\"EOP Selected SCXW61959956 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n\t<div id=\"gap-1101947693\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1101947693 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h3><strong><span class=\"TextRun MacChromeBold SCXW170068198 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW170068198 BCX0\">La FDA a intensifi\u00e9 ses lettres d&#039;avertissement concernant les BPF et ses alertes \u00e0 l&#039;importation.<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-434728685\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-434728685 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW80589066 BCX0\">La FDA a \u00e9mis une s\u00e9rie de lettres d&#039;avertissement faisant \u00e9tat de graves carences en mati\u00e8re de BPF (Bonnes Pratiques de Fabrication).\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">(<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">installations de fabrication st\u00e9rile, de production de principes actifs pharmaceutiques (API) et de sous-traitance<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">)\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">et une r\u00e9tention accrue sans examen physique des m\u00e9dicaments non conformes aux BPF \u00e0 la fronti\u00e8re. C\u2019est cette combinaison qui rend la situation grave\u00a0: une lettre d\u2019avertissement nuit \u00e0 la r\u00e9putation d\u2019un site, tandis que la r\u00e9tention \u00e0 l\u2019importation transforme un constat de non-conformit\u00e9 en une sanction imm\u00e9diate.\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">approvisionnement en<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">\u00a0interruption. L&#039;assurance de la st\u00e9rilit\u00e9, l&#039;int\u00e9grit\u00e9 des donn\u00e9es et les contr\u00f4les des API ont \u00e9t\u00e9 r\u00e9currents dans les lettres.<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">,\u00a0<\/span><span class=\"NormalTextRun SCXW80589066 BCX0\">C\u2019est pr\u00e9cis\u00e9ment l\u00e0 o\u00f9 la r\u00e9solution des probl\u00e8mes est la plus lente. Un site faisant l\u2019objet d\u2019une alerte \u00e0 l\u2019importation peut \u00eatre bloqu\u00e9 sur le march\u00e9 am\u00e9ricain bien avant que les probl\u00e8mes sous-jacents ne soient r\u00e9solus.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW76108789 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW76108789 BCX0\">L&#039;agence japonaise PMDA a publi\u00e9 les r\u00e9sultats de son inspection des BPF.<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-1276292613\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1276292613 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW28283816 BCX0\">L&#039;agence japonaise PMDA a publi\u00e9 un rapport d&#039;inspection des BPF ax\u00e9 sur la gestion des principes actifs pharmaceutiques. Ces rapports sont pr\u00e9cieux, contrairement aux recommandations g\u00e9n\u00e9riques\u00a0: ils r\u00e9v\u00e8lent les attentes r\u00e9elles des inspecteurs et les d\u00e9faillances sp\u00e9cifiques qu&#039;ils signalent, ce qui est bien plus exploitable que des principes abstraits. Les \u00e9quipes qualit\u00e9 devraient exploiter ces rapports pour identifier les points de contr\u00f4le concrets qui importent aux inspecteurs.\u00a0<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">(<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">\u00c9chantillonnage, documentation, qualification des fournisseurs<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">)<\/span><span class=\"NormalTextRun SCXW28283816 BCX0\">\u00a0et comparer leur propre supervision des API aux r\u00e9sultats obtenus avant qu&#039;un inspecteur ne le fasse.<\/span><\/p>\n<h3><strong><span class=\"TextRun MacChromeBold SCXW154821105 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW154821105 BCX0\">La R\u00e9publique dominicaine a \u00e9tendu ses inspections aux m\u00e9dicaments import\u00e9s.<\/span><\/span><\/strong><\/h3>\n\t<div id=\"gap-876612495\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-876612495 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW41450848 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW41450848 BCX0\">L&#039;agence dominicaine DIGEMAPS a \u00e9tendu ses directives d&#039;inspection des BPF aux m\u00e9dicaments fabriqu\u00e9s \u00e0 l&#039;\u00e9tranger et import\u00e9s. Cette extension aux sites \u00e9trangers s&#039;inscrit dans une tendance r\u00e9gionale plus large\u00a0: les autorit\u00e9s r\u00e9glementaires exigent de plus en plus de garanties sur l&#039;ensemble de la cha\u00eene de fabrication, et non plus seulement sur les installations nationales. Pour les fabricants exportant vers ces march\u00e9s, le statut BPF d&#039;un site \u00e9tranger peut d\u00e9sormais \u00eatre pris en compte.\u00a0<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\">d\u00e9terminer<\/span><span class=\"NormalTextRun SCXW41450848 BCX0\"> L&#039;acc\u00e8s \u00e0 des march\u00e9s qui d\u00e9pendaient auparavant du contr\u00f4le du pays exportateur est d\u00e9sormais impossible, et un probl\u00e8me dans une usine peut entra\u00eener la fermeture simultan\u00e9e de plusieurs march\u00e9s.<\/span><\/span><span class=\"EOP SCXW41450848 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n<h3><strong><span class=\"NormalTextRun SCXW224609958 BCX0\">Quoi\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">fait ceci<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">signifier<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">\u00a0pour\u00a0<\/span><span class=\"NormalTextRun SCXW224609958 BCX0\">fabricants ?<\/span><\/strong><\/h3>\n\t<div id=\"gap-2140872301\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2140872301 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"NormalTextRun SCXW116620405 BCX0\">Avec l&#039;intensification des contr\u00f4les de la FDA \u00e0 ses fronti\u00e8res et au-del\u00e0, et l&#039;extension du champ d&#039;action des inspections au Japon et en Am\u00e9rique latine, l&#039;application des BPF s&#039;intensifie et <\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">mondialisation<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">. Tester la pression des r\u00e9gulateurs de contr\u00f4le\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">citant<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">(<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">assurance st\u00e9rile, int\u00e9grit\u00e9 des donn\u00e9es et gestion des API<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">)<\/span><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0et v\u00e9rifier la conformit\u00e9 des importations avant de retenir les exp\u00e9ditions. Dans un contexte r\u00e9glementaire de plus en plus strict, le co\u00fbt d&#039;un \u00e9cart par rapport aux BPF se mesure en termes de produits immobilis\u00e9s et de march\u00e9s ferm\u00e9s, et non plus seulement en heures de mise en conformit\u00e9.\u00a0<\/span><a href=\"http:\/\/regask.com\/fr\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW116620405 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW116620405 BCX0\">\u00a0Ce syst\u00e8me permet de suivre les r\u00e9sultats des inspections BPF, les lettres d&#039;avertissement et les alertes \u00e0 l&#039;importation aupr\u00e8s des organismes de r\u00e9glementation internationaux, aidant ainsi les \u00e9quipes de production et de qualit\u00e9 \u00e0 garder une longueur d&#039;avance sur le renforcement des contr\u00f4les.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>GMP enforcement escalated noticeably in mid-2026, and manufacturing inspections carried the highest share of risky regulatory alerts among our top Life Sciences trends. The driver was a clear surge in US FDA action\u00a0(a run of CGMP warning letters paired with expanded import detentions)\u00a0alongside inspection activity in Japan and Latin America. For manufacturing and quality teams,&#8230;<\/p>","protected":false},"author":46,"featured_media":10375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GMP Enforcement 2026: Key Regulatory Changes Ahead<\/title>\n<meta name=\"description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/application-des-bpf-juin-2026\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts &amp; Global Inspections\" \/>\n<meta property=\"og:description\" content=\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/application-des-bpf-juin-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T02:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\"},\"headline\":\"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"articleSection\":[\"Blogs\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\",\"name\":\"GMP Enforcement 2026: Key Regulatory Changes Ahead\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"datePublished\":\"2026-06-30T02:33:30+00:00\",\"description\":\"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/gmp-enforcement-june-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png\",\"width\":800,\"height\":600,\"caption\":\"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/6d86c29c9123b2b67a3ea8e259cdb925\",\"name\":\"Shaffa Renaningtyas\",\"sameAs\":[\"https:\\\/\\\/regask.com\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Application des BPF 2026\u00a0: Principaux changements r\u00e9glementaires \u00e0 venir","description":"D\u00e9couvrez l\u2019application des BPF en 2026 et son impact sur les inspections de fabrication et les alertes r\u00e9glementaires dans le secteur des sciences de la vie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/application-des-bpf-juin-2026\/","og_locale":"fr_FR","og_type":"article","og_title":"GMP Enforcement Escalates: FDA Warning Letters, Import Alerts & Global Inspections","og_description":"Explore GMP enforcement 2026 and its impact on manufacturing inspections and regulatory alerts in the Life Sciences sector.","og_url":"https:\/\/regask.com\/fr\/application-des-bpf-juin-2026\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-06-30T02:33:30+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#article","isPartOf":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925"},"headline":"GMP Enforcement Escalates: FDA Warning Letters, Import &hellip;","datePublished":"2026-06-30T02:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/"},"wordCount":504,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","articleSection":["Blogs"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","url":"https:\/\/regask.com\/gmp-enforcement-june-2026\/","name":"Application des BPF 2026\u00a0: Principaux changements r\u00e9glementaires \u00e0 venir","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","datePublished":"2026-06-30T02:33:30+00:00","description":"D\u00e9couvrez l\u2019application des BPF en 2026 et son impact sur les inspections de fabrication et les alertes r\u00e9glementaires dans le secteur des sciences de la vie.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/gmp-enforcement-june-2026\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/gmp-enforcement-june-2026\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/06\/gmp-enforcement-escalates_-fda-warning-letters-import-alerts-global-inspections.png","width":800,"height":600,"caption":"Gmp Enforcement Escalates Fda Warning Letters Import Alerts & Global Inspections"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/6d86c29c9123b2b67a3ea8e259cdb925","name":"Shaffa Renaningtyas","sameAs":["https:\/\/regask.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/10372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=10372"}],"version-history":[{"count":3,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/10372\/revisions"}],"predecessor-version":[{"id":10376,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/10372\/revisions\/10376"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/10375"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=10372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=10372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=10372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}